𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and antidepressant efficacy of selective serotonin re-uptake inhibitors

✍ Scribed by S. Kasper; G. Höflich; H.-P. Scholl; H.-J. Möller

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
1013 KB
Volume
9
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis

This review deals with the safety and antidepressant efficacy of selective serotonin re-uptake inhibitors (SSRIs). At present, five SSRIs are used therapeutically in European countries (fluvoxamine, fluoxetine, paroxetine, sertraline and citalopram). The antidepressant efficacy of these drugs has been tested both versus placebo and versus reference antidepressants (amitriptyline, imipramine) revealing comparable antidepressant efficacy to the active compounds and a significant superiority compared with placebo. Furthermore, the available studies provide initial evidence that SSRIs have good antidepressant efficacy in severe depression and suggest that they might lead to a faster decline of suicidal tendencies within major depression. Since they have a favourable side-effects profile in sum, compared with tri-and tetracyclic antidepressants, they can be recommended from the aspect of a 'side-effects-derived indication'.

📜 SIMILAR VOLUMES

Hyponatraemia and selective serotonin re
Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients
✍ Dianne Kirby; David Ames 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract Hyponatraemia (serum sodium arbitrarily defined as less than 135 mmol/L) is an increasingly recognised adverse effect of selective serotonin re‐uptake inhibitors (SSRIs). Its precise prevalence and incidence in the elderly are hard to determine because of confounding factors including o

Comparative safety and tolerability of s
Comparative safety and tolerability of selective serotonin reuptake inhibitors
✍ C. Lindsay Devane 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 748 KB

The selective serotonin reuptake inhibitors (SSRIs) have the best established tolerance and safety profile of the available antidepressants. Evidence for this conclusion comes from controlled clinical trials, post-marketing surveillance, prescription audits and case reports. Comparative studies are

Synthesis of some piperazinylpyrazolo[3,
Synthesis of some piperazinylpyrazolo[3,4-b]pyridines as selective serotonin re-uptake inhibitors
✍ Gregory M. Shutske; Joachim E. Roehr 📂 Article 📅 1997 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 551 KB

## Abstract A number of 3‐substituted 6‐piperazinylpyrazolo[3,4‐__b__]pyridines were synthesized from 2,6‐difluoropyridine by directed __ortho__ metallation and sequential intra‐ and intermolecular displacement of fluorine. Three derivatives with a cyano group in the 3‐position showed activity as s

Maternal use of selective serotonin re-u
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations
✍ Bengt A. J. Källén; Petra Otterblad Olausson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## BACKGROUND: Maternal use of selective serotonin re‐uptake inhibitors (SSRIs) has recently been associated with an increased risk for certain malformations. ## METHODS: Using the Swedish Medical Birth Register, we identified women who had reported the use of SSRIs in early pregnanc